S Zoth Lota

Biography

Lota Zoth joined Circassia as an independent Non-Executive Director on 9 February 2015. She is Chair of the Audit and Risk Committee and a member of the Remuneration Committee. Lota is an experienced Board member, and has significant financial experience gained in a number of global public companies. Most recently she was CFO at MedImmune, and she previously held senior positions at PSINet, Sodexho Marriott, PepsiCo and Ernst & Young. She is currently a Non-Executive Director at Hyperion Therapeutics Inc, NewLink Genetics Corporation, Orexigen Therapeutics Inc., and Spark Therapeutics. She is also Chair of Aeras, a non-profit product development organisation focused on tuberculosis and funded by The Bill and Melinda Gates Foundation, and until 2014 was a Non-Executive Director at privately-held biopharmaceutical company Ikaria Inc. Lota has over 30 years’ experience as a Certified Public Accountant, and holds a Bachelor of Business Administration from Texas Tech University. Lota Zoth joined Circassia as an independent Non-Executive Director on 9 February 2015. She is Chair of the Audit and Risk Committee and a member of the Remuneration Committee. Lota is an experienced Board member, and has significant financial experience gained in a number of global public companies. Most recently she was CFO at MedImmune, and she previously held senior positions at PSINet, Sodexho Marriott, PepsiCo and Ernst & Young. She is currently a Non-Executive Director at Hyperion Therapeutics Inc, NewLink Genetics Corporation, Orexigen Therapeutics Inc., and Spark Therapeutics. She is also Chair of Aeras, a non-profit product development organisation focused on tuberculosis and funded by The Bill and Melinda Gates Foundation, and until 2014 was a Non-Executive Director at privately-held biopharmaceutical company Ikaria Inc. Lota has over 30 years’ experience as a Certified Public Accountant, and holds a Bachelor of Business Administration from Texas Tech University.

Research Interest

biopharmaceutical